Claims for Patent: 5,935,799

Summary for Patent: 5,935,799

Title:	Biological assay for microbial contamination
Abstract:	A semi-quantitative method for determining the concentration of viable coliforms or E. coli in a liquid is provided. The sample to be tested is mixed with an indicator reagent which includes a specific indicator compound that undergoes a change that is detectable by spectrophotometric or visual methods upon cleavage by a beta galactosidase enzyme found in coliforms or a beta glucuronidase enzyme unique to E. coli.
Inventor(s):	Isbister; Jenefir D. (Potomac, MD)
Assignee:	George Mason University (Fairfax, VA)
Application Number:	08/988,239
Patent Claims:	1. A method for determining the concentration of viable coliforms or E. coli in a liquid, comprising the steps of: obtaining a sample of said liquid to be tested from a source where contamination is suspected; mixing said sample with an indicator reagent in a container to form a liquid test sample, wherein said indicator reagent includes an indicator compound that undergoes a change detectable by spectrophotometric or visual methods upon cleavage by a beta galactosidase enzyme found in coliform or a beta glucuronidase enzyme unique to E. coli; detecting spectrophotometrically or visually said detectable change in said indicator compound in said liquid test sample due to viable coliform or E. coli being in contact with said indicator reagent; measuring an elapsed time for said detectable change in said indicator compound to occur in said liquid test sample, said elapsed time indicating the concentration of viable coliform or E. coli in said liquid at the time of selection of said sample, whereby only one liquid test sample is used to determine said concentration in said liquid. 2. The method of claim 1, wherein said liquid sample to be tested is water. 3. The method of claim 1, wherein said indicator reagent comprises: i) buffer that maintains a pH of about 7, ii) tryptic soy broth without glucose, iii) succinate, iv) isopropylthiogalactopyranoside; and v) an indicator compound that undergoes a color change upon cleavage by beta galactosidase. 4. The method of claim 1, wherein the indicator reagent comprises: i) buffer that maintains a pH of about 7, ii) tryptic soy broth without glucose, and iii) an indicator compound that undergoes a detectable change upon cleavage by beta glucuronidase, and wherein said indicator reagent does not contain succinate. 5. The method of claim 1, wherein said indicator compound is orthonitrophenyl galactoside for detecting coliforms. 6. The method of claim 1, wherein said indicator compound is methylumbelliferyl glucuronide for detecting E. coli. 7. The method of claim 5, wherein the concentration of orthonitrophenyl galactoside in the sample is about 0.5 to about 5 mg/ml of sample. 8. The method of claim 6, wherein the concentration of methylumbelliferyl glucuronide in the sample is about 0.05 to about 0.5 mg/ml of sample. 9. The method of claim 7 or 8, wherein said detecting step is performed spectrophotometrically at predetermined intervals until a change in absorbance of about 0.05 absorbance units has occurred. 10. The method of claim 7 or 8, wherein said detecting step is performed visually at predetermined intervals until a bright yellow color as compared to the control is observed for the coliform test or a fluorescent blue color is observed under long wave UV for the E. coli test. 11. The method of claim 1, wherein said step of measuring an elapsed time for said detectable change in said indicator compound includes the step of: periodically comparing said liquid sample in said container from the time said indicator reagent is mixed with the liquid sample with a control liquid sample contained in a second container, wherein said control liquid sample is devoid of said indicator reagent, until said detectable change is observed in said liquid sample including said indicator reagent by comparison to said control sample devoid of said indicator reagent wherein a third container containing sterile water with said indicator reagent is used as a blank for the spectrophotometric determinations. 12. The method of claim 11, further comprising a step of incubating said container containing said liquid sample and said second container containing said control liquid sample. 13. The method of claim 1, wherein said elapsed time to detect about 20 viable coliforms/ml spectrophotometrically is within about 10 h, and visually is within about 11.5 h. 14. The method of claim 1, wherein said elapsed time to detect about 10 viable E. coli/ml spectrophotometrically is within about 10 h, and visually is within about 12 h. 15. A method of claim 1, wherein said concentration of viable coliforms or E. coli in said liquid is cfu/ml. 16. A method of claim 1, with the proviso that the method is not most probable number analysis. 17. A method of claim 1, further comprising determining at predetermined intervals whether said detectable change in said indicator compound has occurred. 18. A method of claim 17, wherein the predetermined intervals are hourly. 19. A kit for detecting the concentration of viable coliforms in a liquid sample, comprising: a first container for holding said liquid sample; and a second container comprising an indicator reagent under vacuum, whereby said second container is insertable into said first container, whereby releasing said vacuum in said second container when said second container is positioned within said first container, results in the filling of said second container with said liquid sample present in said first container, and wherein said indicator reagent undergoes a visible or spectrophotometrically detectable change upon cleavage as a result of contact with a viable coliform producing a beta-galactosidase enzyme. 20. A kit of claim 19, wherein said indicator reagent is orthonitrophenyl galactoside. 21. A kit of claim 19, wherein said indicator reagent is positionable within said second container. 22. The kit according to claim 19, wherein said indicator reagent is methylumbelliferyl glucuronide for detecting E. coli. 23. A kit for detecting the concentration of viable E. coli in a liquid sample, comprising: a first container for holding said liquid sample; and a second container comprising an indicator reagent under vacuum, whereby said second container is insertable into said first container, whereby releasing said vacuum in said second container when said second container is positioned within said first container, results in the filling of said second container with said liquid sample present in said first container, and wherein said indicator reagent undergoes a visible or spectrophotometrically detectable change upon cleavage as a result of contact with a viable coliform producing a beta-galactosidase enzyme. 24. A kit of claim 23, wherein said indicator regent is orthonitrophenyl galactoside. 25. A kit of claim 23, wherein said indicator reagent is positionable within said second container.

Details for Patent 5,935,799

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23